trelstar and Uterine-Cervical-Neoplasms

trelstar has been researched along with Uterine-Cervical-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for trelstar and Uterine-Cervical-Neoplasms

Article	Year
Regression of the malignant aspects of intraepithelial neoplasias following an LH-RH agonist treatment and detection of human papillomavirus by molecular hybridization. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:3 Patients presenting genital intraepithelial neoplasia and/or flat condyloma were treated with DTrp6-LH-RH (triptorelin) to induce a transitory suppression of estrogens. This treatment led in some cases to a complete clinical and histological regression accompanied by a disappearance of human papillomavirus sequences as detected by molecular hybridization. Topics: Antineoplastic Agents; Female; Gonadotropin-Releasing Hormone; Humans; Papillomaviridae; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms	1989
Triptorelin in treatment of cervical and vaginal dysplasia related to papillomavirus. Lancet (London, England), 1988, Apr-09, Volume: 1, Issue:8589 Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Papillomaviridae; Time Factors; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms; Vaginal Neoplasms	1988

Article

Year

Regression of the malignant aspects of intraepithelial neoplasias following an LH-RH agonist treatment and detection of human papillomavirus by molecular hybridization.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1989, Volume: 43, Issue:3

Patients presenting genital intraepithelial neoplasia and/or flat condyloma were treated with DTrp6-LH-RH (triptorelin) to induce a transitory suppression of estrogens. This treatment led in some cases to a complete clinical and histological regression accompanied by a disappearance of human papillomavirus sequences as detected by molecular hybridization.

Topics: Antineoplastic Agents; Female; Gonadotropin-Releasing Hormone; Humans; Papillomaviridae; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms

1989

Triptorelin in treatment of cervical and vaginal dysplasia related to papillomavirus.

Lancet (London, England), 1988, Apr-09, Volume: 1, Issue:8589

Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Humans; Middle Aged; Papillomaviridae; Time Factors; Triptorelin Pamoate; Tumor Virus Infections; Uterine Cervical Neoplasms; Vaginal Neoplasms

1988